Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin
Author:
Funder
U.S. Food and Drug Administration
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Link
https://link.springer.com/content/pdf/10.1007/s40264-021-01072-0.pdf
Reference27 articles.
1. Cohen H, Arachchillage DRJ, Beyer-Westendorf J, Middeldorp S, Kadir RA. Direct oral anticoagulants and women. Semin Thromb Hemost. 2016;42(07):789–97.
2. Myers B, Webster A. Heavy menstrual bleeding on rivaroxaban—comparison with apixaban. Br J Haematol. 2017;176(5):833–5.
3. Beyer-Westendorf J, Michalski F, Tittl L, Hauswald-Dörschel S, Marten S. Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series. Lancet Haematol. 2016;3(10):e480–8.
4. Ferreira M. Direct oral anti-Xa inhibitors and vaginal bleeding. Lancet Haematol. 2016;3(10):e451–2.
5. Ferreira M, Barsam S, Patel JP, Czuprynska J, Roberts LN, Patel RK, et al. Heavy menstrual bleeding on rivaroxaban. Br J Haematol. 2016;173(2):314–5.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Life-threatening vaginal bleeding after starting rivaroxaban treatment;Ugeskrift for Læger;2024-05-27
2. Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment;Pharmacoepidemiology and Drug Safety;2024-05-23
3. Innovations in pharmacovigilance studies of medicines in older people;British Journal of Clinical Pharmacology;2024-03-26
4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism;Thrombosis Update;2023-12
5. Abnormal uterine bleeding in anticoagulated patients by drug class: outcomes and management;American Journal of Obstetrics and Gynecology;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3